New DBS device for Parkinson’s approved for US patients

News

Author: AdminPublished: 24 June 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

The US Food and Drug Administration (FDA) has approved a new implantable deep brain stimulation device (DBS) called the Brio Neurostimulation System.

Previously the Activa DBS Therapy System manufactured by Medtronic was the only device available to patients in the US.

Like the Activa system, the newly approved Brio system consists of a battery-powered rechargeable electrical pulse generator that is inserted under the skin of the upper chest and wires that lead to electrodes implanted in the brain.

The new Brio system is made by St. Jude Medical.

Go Back

Share this story

Comments


Related articles


Global update

Five incredible feats by people living with Parkinson’s

From 500-mile walks to international tours

READ MORE
umotif-100-for-parkinsons-app-lead

Special reports

100 for Parkinson’s: patients suffer lower moods, higher stress levels and poorer sleep quality

Latest findings from 100 for Parkinson’s study released

READ MORE

Interviews

The filmmaker challenging the “miserable” media surrounding Parkinson’s

We talk to award-winning director and filmmaker Grant Taylor

READ MORE